INSIGHTS ON CLINICAL TRIAL PARTNERING

• Strategies For A More Secure Outsourcing Bottom Line

  A panel of experts from across the pharmaceutical/biopharmaceutical industry recently shared their experiences in mitigating financial risk before partnering with a contract research organization (CRO).

• Reduce Patient And Site Burden Through Excellence In Trial Logistics

  Watch for an insightful webinar where you’ll explore the latest strategies and innovations for managing clinical trial operations with a focus on device provisioning and data workflows.

• How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?

  By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.

• Clinical Trial Payments And Ethics: Your Top Questions Answered

  Fair compensation in trials requires distinguishing reimbursement from stipends. Learn the ethical principles that ensure payments uphold participant respect and remove financial barriers.

• How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs

  3/17/2025

  Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

• The Real Power Of Digital Payments In Clinical Trials

  10/8/2025

  Digital payments streamline clinical trials by reducing site burden, improving patient experience, eliminating manual delays, and delivering cleaner data across global studies.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  8/22/2025

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• The Defensiveness Trap In Vendor Selection And Management

  8/22/2025

  In clinical research, sponsor–vendor relationships are often framed as negotiations. Yet while both sides want to achieve a successful study, the process often becomes a tug-of-war.

• Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials

  4/11/2025

  Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.